Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1811 1
1948 1
1958 1
1986 3
1990 1
1992 1
1999 2
2000 3
2001 1
2002 1
2003 3
2004 2
2005 4
2006 5
2007 7
2008 5
2009 3
2010 4
2011 11
2012 13
2013 11
2014 19
2015 20
2016 11
2017 8
2018 7
2019 10
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25495287

133 results
Results by year
Filters applied: . Clear all
Page 1
Trismus, xerostomia and nutrition status in nasopharyngeal carcinoma survivors treated with radiation.
Chen YJ, Chen SC, Wang CP, Fang YY, Lee YH, Lou PJ, Ko JY, Chiang CC, Lai YH. Chen YJ, et al. Eur J Cancer Care (Engl). 2016 May;25(3):440-8. doi: 10.1111/ecc.12270. Epub 2014 Dec 11. Eur J Cancer Care (Engl). 2016. PMID: 25495287
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X, Zhou X, Shi Q, Xing X, Yang Y, Xu T, Shen C, Wang X, He X, Kong L, Ying H, Hu C. Ou X, et al. Oncotarget. 2015 Nov 10;6(35):38381-97. doi: 10.18632/oncotarget.5420. Oncotarget. 2015. PMID: 26485757 Free PMC article.
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, Ezzat S, Pothier D, Bernstein LJ, So N, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J. McDowell LJ, et al. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):340-352. doi: 10.1016/j.ijrobp.2018.05.060. Epub 2018 Jun 4. Int J Radiat Oncol Biol Phys. 2018. PMID: 30191868
Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
Chen YY, Zhao C, Wang J, Ma HL, Lai SZ, Liu Y, Han F, Lu LX, Bao Y, Chen M. Chen YY, et al. Cancer. 2011 Jul 1;117(13):2910-6. doi: 10.1002/cncr.25773. Epub 2011 Jan 24. Cancer. 2011. PMID: 21264821 Free article. Clinical Trial.
Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y, Han F, Xiao W, Xiang Y, Lu L, Deng X, Cui N, Zhao C. Zheng Y, et al. Radiat Oncol. 2015 Jan 13;10:17. doi: 10.1186/s13014-014-0326-z. Radiat Oncol. 2015. PMID: 25582731 Free PMC article.
Radiation-induced temporo-mandibular joint disorder in post-radiotherapy nasopharyngeal carcinoma patients: assessment and treatment.
Wu VW, Lam YN. Wu VW, et al. J Med Radiat Sci. 2016 Jun;63(2):124-32. doi: 10.1002/jmrs.145. Epub 2015 Nov 20. J Med Radiat Sci. 2016. PMID: 27350892 Free PMC article. Review.
Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF, Han F, Zhao C, Chen CY, Xiao WW, Li JX, Lu TX. Su SF, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):327-33. doi: 10.1016/j.ijrobp.2010.09.011. Epub 2010 Oct 29. Int J Radiat Oncol Biol Phys. 2012. PMID: 21035959
XRCC3 polymorphisms are associated with the risk of developing radiation-induced late xerostomia in nasopharyngeal carcinoma patients treated with intensity modulation radiated therapy.
Zou Y, Song T, Yu W, Zhao R, Wang Y, Xie R, Chen T, Wu B, Wu S. Zou Y, et al. Jpn J Clin Oncol. 2014 Mar;44(3):241-8. doi: 10.1093/jjco/hyt202. Epub 2014 Jan 22. Jpn J Clin Oncol. 2014. PMID: 24453273
Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K, Hussain A, Ong WS, Yit NLF, Khoo JBK, Soong YL, Wee JTS, Fong KW, Tan TWK. Sommat K, et al. Radiother Oncol. 2019 Sep;138:149-157. doi: 10.1016/j.radonc.2019.05.023. Epub 2019 Jun 29. Radiother Oncol. 2019. PMID: 31265972
Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
Lee TF, Liou MH, Ting HM, Chang L, Lee HY, Wan Leung S, Huang CJ, Chao PJ. Lee TF, et al. Sci Rep. 2015 Aug 20;5:13165. doi: 10.1038/srep13165. Sci Rep. 2015. PMID: 26289304 Free PMC article.
133 results
Jump to page